Recent Advances with Liposomes as Drug Carriers - Advanced Biomaterials and Biodevices - page 115

226. Gao, J.Q., et al. , Glioma targeting and Blood -brain barrier penetration by
dual-targeting doxorubincin liposomes. Biomaterials , 2013. 34(22): p.
5628-39.
227. Ying, X., et al. , Dual-targeting daunorubicin liposomes improve the thera-
peutic ei cacy of brain glioma in animals. J Control Release , 2010. 141(2): p.
183-92.
228. Jiang, T., et al. , Dual-functional liposomes based on pH-responsive cell-
penetrating peptide and hyaluronic acid for tumor-targeted anticancer Drug
Deliv ery. Biomaterials , 2012. 33(36): p. 9246-58.
229. Kibria, G., et al. , Dual-ligand modii cation of PEGylated liposomes shows
better cell selectivity and ei cient gene delivery. J Control Release , 2011.
153(2): p. 141-8.
230. Kluza, E., et al. , Synergistic targeting of alphavbeta3 integrin and galectin-1
with heteromultivalent paramagnetic liposomes for combined MR imaging
and treatment of angiogenesis. Nano Lett , 2010. 10(1): p. 52-8.
231. Kluza, E., et al. , Dual-targeting of alphavbeta3 and galectin-1 improves the
specii city of paramagnetic/l uorescent liposomes to tumor endothelium in
vivo. J Control Release , 2012. 158(2): p. 207-14.
232. Ko, Y.T., et al. , Gene delivery into ischemic myocardium by double-targeted
lipoplexes with anti-myosin antibody and TAT peptide. Gene h er , 2009.
16(1): p. 52-9.
233. Kwong, B., et al. , Localized immunotherapy via liposome-anchored
Anti-CD137 + IL-2 prevents lethal toxicity and elicits local and systemic
antitumor immunity. Cancer Res , 2013. 73(5): p. 1547-58.
234. Laginha, K., D. Mumbengegwi, and T. Allen, Liposomes targeted via two
dif erent antibodies: assay, B-cell binding and cytotoxicity. Biochim Biophys
Acta , 2005. 1711(1): p. 25-32.
235. Yu, B., et al. , Targeted Drug Deliv ery and cross-linking induced apoptosis
with anti-CD37 based dual-ligand immunoliposomes in B chronic lympho-
cytic leukemia cells. Biomaterials , 2013. 34(26): p. 6185-93.
236. Torchilin, V.P., Multifunctional nanocarriers. Advanced Drug Delivery
Reviews , 2006. 58(14): p. 1532-1555.
237. Hansen, M.B., et al. , Constrained and UV-activatable cell-penetrating pep-
tides for intracellular delivery of liposomes. J Control Release , 2012. 164(1):
p. 87-94.
238. Kale, A.A. and V.P. Torchilin, “Smart” drug carriers: PEGylated TATp-
modii ed pH-sensitive liposomes. J Liposome Res , 2007. 17(3-4): p. 197-203.
239. Kale, A.A. and V.P. Torchilin, Enhanced transfection of tumor cells in vivo
using “Smart” pH-sensitive TAT-modii ed pegylated liposomes. J Drug
Target , 2007. 15(7-8): p. 538-45.
240. Schafer, J., et al. , Liposome-polyethylenimine complexes for enhanced DNA
and siRNA delivery. Biomaterials , 2010. 31(26): p. 6892-900.
241. Adil, M., et al. , PR_b functionalized stealth liposomes for targeted delivery
to metastatic colon cancer. Biomaterials Science , 2013. 1(4): p. 393.